KKR to Acquire RPS from Warburg Pincus
Global investment firm KKR said Wednesday that it has inked an agreement to buy ReSearch Pharmaceutical Services from Warburg Pincus. No financial terms were disclosed. Citigroup acted as exclusive financial advisor to RPS for the transaction while Credit Suisse, Jefferies and UBS Investment Bank served as financial advisors to KKR. Also, debt financing will be provided by Credit Suisse, Jefferies, UBS Investment Bank, Citigroup and KKR Capital Markets. When the transaction closes, which is expected to be in the third quarter of 2013, RPS will merge with PRA International, another recent KKR acquisition. Headquartered in Fort Washington, Penn., RPS is a global contract research organization.





